| Record Information |
| Version |
3.5 |
| Creation Date |
2005-11-16 08:48:42 -0700 |
| Update Date |
2013-02-08 17:09:11 -0700 |
| HMDB ID |
HMDB00725 |
| Secondary Accession Numbers |
None |
| Metabolite Identification |
| Common Name |
Hydroxyproline |
| Description |
Hydroxyproline is an uncommon amino acid. Hydroxyproline differs from proline by the presence of a hydroxyl (OH) group attached to the C (gamma) atom. Hydroxyproline is produced by hydroxylation of the amino acid proline. It is not directly coded for by DNA, however, and is hydroxylated after protein synthesis. Hydroxyproline is a major component of the protein collagen. Hydroxyproline and proline play key roles for collagen stability. They permit the sharp twisting of the collagen helix. It helps provide stability to the triple-helical structure of collagen by forming hydrogen bonds. Hydroxyproline is found in few proteins other than collagen. The only other mammalian protein which includes hydroxyproline is elastin. For this reason, hydroxyproline content has been used as an indicator to determine collagen and/or gelatin amount. Proline hydroxylation requires ascorbic acid. The most obvious, first effects (gum and hair problems) of absence of ascorbic acid in humans come from the resulting defect in hydroxylation of proline residues of collagen, with reduced stability of the collagen molecule causing scurvy. (http://en.wikipedia.org/wiki/Hydroxyproline). Hydroxyproline levels increase in cases of psychotic depression. These patients also may require extra vitamin C. (http://www.dcnutrition.com/AminoAcids). |
| Structure |
Download:
MOL |
SDF |
SMILES |
InChI
Display:
2D Structure |
3D Structure
|
| Synonyms |
- (2S,4R)-4-hydroxy-2-pyrrolidinecarboxylic acid
- (2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid
- (4R)-4-hydroxy-L-proline
- 4-Hydroxy-2-pyrrolidinecarboxylic acid
- 4-Hydroxy-L-proline
- 4-Hydroxyproline
- 4-L-Hydroxyproline
- delta-Hydroxyproline
- Hydroxiproline
- Hydroxy-L-proline
- Hydroxy-proline
- Hydroxyproline
- L-4-Hydroxyproline
- L-Hydroxyproline
- L-Threo-4-hydroxyproline
- LS-hydroxyproline
- Oxaceprol
- trans-4-Hydroxy-L-proline
- trans-4-Hydroxyproline
- Trans-hydroxyproline
- Trans-L-hydroxyproline
|
| Chemical Formula |
C5H9NO3 |
| Average Molecular Weight |
131.1299 |
| Monoisotopic Molecular Weight |
131.058243159 |
| IUPAC Name |
(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid |
| Traditional IUPAC Name |
hydroxyproline |
| CAS Registry Number |
51-35-4 |
| SMILES |
O[C@H]1CN[C@@H](C1)C(O)=O |
| InChI Identifier |
InChI=1S/C5H9NO3/c7-3-1-4(5(8)9)6-2-3/h3-4,6-7H,1-2H2,(H,8,9)/t3-,4+/m1/s1 |
| InChI Key |
PMMYEEVYMWASQN-DMTCNVIQSA-N |
| Chemical Taxonomy |
| Kingdom |
Organic Compounds |
| Super Class |
Amino Acids, Peptides, and Analogues |
| Class |
Amino Acids and Derivatives |
| Sub Class |
Alpha Amino Acids and Derivatives |
| Other Descriptors |
- Aliphatic Heteromonocyclic Compounds
- amino acid zwitterion(ChEBI)
|
| Substituents |
- 1,2 Aminoalcohol
- Carboxylic Acid
- Pyrrolidine
- Pyrrolidine Carboxylic Acid
- Secondary Alcohol
- Secondary Aliphatic Amine (Dialkylamine)
|
| Direct Parent |
Alpha Amino Acids and Derivatives |
| Ontology |
| Status |
Detected and Quantified |
| Origin |
|
| Biofunction |
- Component of Arginine and proline metabolism
|
| Application |
Not Available |
| Cellular locations |
- Mitochondria
- Endoplasmic reticulum
|
| Physical Properties |
| State |
Solid |
| Experimental Properties |
| Property |
Value |
Reference |
| Melting Point |
274 - 275 °C |
Not Available |
| Boiling Point |
Not Available |
Not Available |
| Water Solubility |
361 mg/mL at 25 °C |
Not Available |
| LogP |
-3.17 |
HANSCH,C ET AL. (1995) |
|
| Predicted Properties |
|
| Spectra |
|
| Gas-MS Spectrum |
| 13C NMR Spectrum |
| 1H NMR Spectrum |
| MS/MS Spectrum Quattro_QQQ 10 |
| MS/MS Spectrum Quattro_QQQ 25 |
| MS/MS Spectrum Quattro_QQQ 40 |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies ) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies ) |
| MS/MS Spectrum GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies) |
| MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) |
| MS/MS Spectrum LC-ESI-QTOF (UPLC Q-Tof Premier, Waters) |
| MS/MS Spectrum GC-MS |
| MS/MS Spectrum GC-MS |
| [1H,1H] 2D NMR Spectrum |
| [1H,13C] 2D NMR Spectrum |
|
| Biological Properties |
| Cellular Locations |
- Mitochondria
- Endoplasmic reticulum
|
| Biofluid Locations |
|
| Tissue Location |
- Muscle
- Skeletal Muscle
- Fibroblasts
- Pancreas
- Placenta
- Kidney
- Liver
- Prostate
- Skin
- Platelet
- Spleen
- Gingiva
|
| Pathways |
Not Available
|
| Normal Concentrations |
|
| Blood |
Detected and Quantified |
|
11.8 (9.9-13.7) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
40.0 (28.0-55.0) uM |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Blood |
Detected and Quantified |
|
40.0 +/- 40.0 uM |
Newborn (0-30 days old) |
Not Specified |
Normal |
Blood plasma from 46 individuals
|
| Blood |
Detected and Quantified |
|
24.0 +/- 13.0 uM |
Children (1-13 year old) |
Male |
Normal |
Blood plasma from 36 boys
|
| Blood |
Detected and Quantified |
|
20.0 +/- 12.0 uM |
Children (1-13 year old) |
Female |
Normal |
Blood plasma from 34 girls
|
| Blood |
Detected and Quantified |
|
20.0 +/- 11.0 uM |
Adult (>18 years old) |
Male |
Normal |
Blood plasma from 83 men
|
| Blood |
Detected and Quantified |
|
16.0 +/- 9.0 uM |
Adult (>18 years old) |
Female |
Normal |
Blood plasma from 92 women
|
| Blood |
Detected and Quantified |
|
13.0 (3.0-23.0) uM |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
<3.289 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
1.37 +/- 0.78 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2.0 (2.15-3.36) umol/mmol creatinine |
Newborn (0-30 days old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
2 umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
Not Available |
| Urine |
Detected and Quantified |
|
6.5 (2.4-12.5) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Normal |
urine by NMR
|
| Urine |
Detected and Quantified |
|
88.17 +/- 49.59 umol/mmol creatinine |
Infant (0-1 year old) |
Both |
Normal |
Not Available |
|
| Abnormal Concentrations |
|
| Blood |
Detected and Quantified |
|
5.66 +/- 0.67 uM |
Elderly (>65 years old) |
Both |
Alzheimer's disease |
Not Available |
| Blood |
Detected and Quantified |
|
43.8 +/- 12.5 uM |
Adult (>18 years old) |
Both |
Hemodialysis |
Conventional: for 4 h, 3 times/week
|
| Blood |
Detected and Quantified |
|
27.0 +/- 14.1 uM |
Adult (>18 years old) |
Both |
Hemodialysis |
Nocturnal: for 8 h during the night, 6 times/week
|
| Blood |
Detected and Quantified |
|
45.5 (0.00-91.00) uM |
Adult (>18 years old) |
Both |
Hydroxyprolinemia |
Not Available |
| Blood |
Detected and Quantified |
|
550.00 (100.00-1000.00) uM |
Adult (>18 years old) |
Both |
Hydroxyprolinemia |
Not Available |
| Urine |
Detected and Quantified |
|
15.7 (2.6-29.00) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Hydroxyprolinemia |
Not Available |
| Urine |
Detected and Quantified |
|
188.00 (100.00-276.00) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Hydroxyprolinemia |
Not Available |
| Urine |
Detected and Quantified |
|
49.00 (32.8-65.7) umol/mmol creatinine |
Adult (>18 years old) |
Both |
Iminoglycinuria |
Not Available |
|
| Associated Disorders and Diseases |
| Disease References |
| Alzheimer's disease |
- Fonteh AN, Harrington RJ, Tsai A, Liao P, Harrington MG: Free amino acid and dipeptide changes in the body fluids from Alzheimer's disease subjects. Amino Acids. 2007 Feb;32(2):213-24. Epub 2006 Oct 10.
Pubmed: 17031479
|
| Hemodialysis |
- Raj DS, Ouwendyk M, Francoeur R, Pierratos A: Plasma amino acid profile on nocturnal hemodialysis. Blood Purif. 2000;18(2):97-102.
Pubmed: 10838467
|
| Hydroxyprolinemia |
- http://www.metagene.de/program/d.prg?mp=HYDROXYPROLINEMIA
|
| Iminoglycinuria |
- http://www.metagene.de/program/d.prg?mp=IMINOGLYCINURIA
|
|
| Associated OMIM IDs |
|
| External Links |
| DrugBank ID |
Not Available |
| Phenol Explorer Compound ID |
Not Available |
| Phenol Explorer Metabolite ID |
Not Available |
| FoodDB ID |
FDB013511 |
| KNApSAcK ID |
Not Available |
| Chemspider ID |
5605  |
| KEGG Compound ID |
C01157  |
| BioCyc ID |
L-4-HYDROXY-PROLINE  |
| BiGG ID |
36935  |
| Wikipedia Link |
Hydroxyproline  |
| NuGOwiki Link |
HMDB00725  |
| Metagene Link |
HMDB00725  |
| METLIN ID |
257  |
| PubChem Compound |
5810  |
| PDB ID |
HYP  |
| ChEBI ID |
18095  |
| References |
| Synthesis Reference |
Adams, Elijah; Goldstone, Alfred. Hydroxyproline metabolism. II. Enzymic preparation and properties of D1-pyrroline-3-hydroxy-5-carboxylic acid. Journal of Biological Chemistry (1960), 235 3492-8. |
| Material Safety Data Sheet (MSDS) |
Download (PDF)
|
| General References |
- Matsuda Y, Matsumoto K, Yamada A, Ichida T, Asakura H, Komoriya Y, Nishiyama E, Nakamura T: Preventive and therapeutic effects in rats of hepatocyte growth factor infusion on liver fibrosis/cirrhosis. Hepatology. 1997 Jul;26(1):81-9.
Pubmed: 9214455
- Seibel MJ, Woitge HW: Basic principles and clinical applications of biochemical markers of bone metabolism: biochemical and technical aspects. J Clin Densitom. 1999 Fall;2(3):299-321.
Pubmed: 10548826
- Kelleher PC: Urinary excretion of hydroxyproline, hydroxylysine and hydroxylysine glycosides by patients with Paget's disease of bone and carcinoma with metastases in bone. Clin Chim Acta. 1979 Mar 15;92(3):373-9.
Pubmed: 436278
- Cynober LA: Plasma amino acid levels with a note on membrane transport: characteristics, regulation, and metabolic significance. Nutrition. 2002 Sep;18(9):761-6.
Pubmed: 12297216
- Akalin FA, Sengun D, Eratalay K, Renda N, Caglayan G: Hydroxyproline and total protein levels in gingiva and gingival crevicular fluid in patients with juvenile, rapidly progressive, and adult periodontitis. J Periodontol. 1993 May;64(5):323-9.
Pubmed: 8515361
- Akalin FA, Sengun D, Renda N, Eratalay K, Caglayan G: Hydroxyproline and total protein levels in gingiva and gingival crevicular fluid in periodontally healthy human subjects. J Nihon Univ Sch Dent. 1992 Sep;34(3):172-7.
Pubmed: 1287145
- Lee HS, Shun CT, Chiou LL, Chen CH, Huang GT, Sheu JC: Hydroxyproline content of needle biopsies as an objective measure of liver fibrosis: Emphasis on sampling variability. J Gastroenterol Hepatol. 2005 Jul;20(7):1109-14.
Pubmed: 15955222
- Akalin FA, Bozkurt FY, Sengun D, Renda N, Kalfa Z, Eratalay K, Velidedeoglu E: Hydroxyproline and total protein levels in gingiva from patients treated with phenytoin and cyclosporine-A. J Nihon Univ Sch Dent. 1996 Mar;38(1):21-30.
Pubmed: 8648408
- Diaz S, Reyes MV, Zepeda A, Gonzalez GB, Lopez JM, Campino C, Croxatto HB: Norplant((R)) implants and progesterone vaginal rings do not affect maternal bone turnover and density during lactation and after weaning. Hum Reprod. 1999 Oct;14(10):2499-505.
Pubmed: 10527977
- Fiorucci S, Rizzo G, Antonelli E, Renga B, Mencarelli A, Riccardi L, Morelli A, Pruzanski M, Pellicciari R: Cross-talk between farnesoid-X-receptor (FXR) and peroxisome proliferator-activated receptor gamma contributes to the antifibrotic activity of FXR ligands in rodent models of liver cirrhosis. J Pharmacol Exp Ther. 2005 Oct;315(1):58-68. Epub 2005 Jun 24.
Pubmed: 15980055
- Kondo A, Ishikawa O, Okada K, Miyachi Y, Abe S, Kuboki Y: Measurement of histidinohydroxylysinonorleucine and hydroxyproline in skin collagen by reversed-phase high-performance liquid chromatography after 9-fluorenylmethyl chloroformate labeling. Anal Biochem. 1997 Oct 15;252(2):255-9.
Pubmed: 9344411
- Gerling B, Becker M, Waldschmidt J, Rehmann M, Schuppan D: Elevated serum aminoterminal procollagen type-III-peptide parallels collagen accumulation in rats with secondary biliary fibrosis. J Hepatol. 1996 Jul;25(1):79-84.
Pubmed: 8836905
- Bienkowski RS: A criterion to determine whether cis-4-hydroxyproline is produced in animal tissues. Arch Biochem Biophys. 1984 Mar;229(2):455-8.
Pubmed: 6703705
- Bellon G, Berg R, Chastang F, Malgras A, Borel JP: Separation and evaluation of the cis and trans isomers of hydroxyprolines: effect of hydrolysis on the epimerization. Anal Biochem. 1984 Feb;137(1):151-5.
Pubmed: 6731795
- Lindblad WJ, Diegelmann RF: Quantitation of hydroxyproline isomers in acid hydrolysates by high-performance liquid chromatography. Anal Biochem. 1984 May 1;138(2):390-5.
Pubmed: 6742416
- Shibasaki T, Mori H, Ozaki A: Enzymatic production of trans-4-hydroxy-L-proline by regio- and stereospecific hydroxylation of L-proline. Biosci Biotechnol Biochem. 2000 Apr;64(4):746-50.
Pubmed: 10830487
- Pickersgill IF, Rapoport H: Preparation of functionalized, conformationally constrained DTPA analogues from L- or D-serine and trans-4-hydroxy-L-proline. Hydroxymethyl substituents on the central acetic acid and on the backbone. J Org Chem. 2000 Jun 30;65(13):4048-57.
Pubmed: 10866623
- Song IK, Kang YK: Conformational preference and cis-trans isomerization of 4(R)-substituted proline residues. J Phys Chem B. 2006 Feb 2;110(4):1915-27.
Pubmed: 16471763
- Baldwin JE, Pritchard GJ, Williamson DS: The synthesis of 4-arylsulfanyl-substituted kainoid analogues from trans-4-hydroxy-L-proline. Bioorg Med Chem Lett. 2000 Sep 4;10(17):1927-9.
Pubmed: 10987419
- Miskolzie M, Gera L, Stewart JM, Kotovych G: The importance of the N-terminal beta-turn in bradykinin antagonists. J Biomol Struct Dyn. 2000 Oct;18(2):249-60.
Pubmed: 11089646
- Kofoed J, Darbre T, Reymond JL: Dual mechanism of zinc-proline catalyzed aldol reactions in water. Chem Commun (Camb). 2006 Apr 14;(14):1482-4. Epub 2006 Mar 2.
Pubmed: 16575434
- Kuttan R, Radhakrishnan AN: Studies on bound trans-4-hydroxy-L-proline in sandal (Santalum album L.). Biochem J. 1970 Oct;119(4):651-7.
Pubmed: 5493503
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4.
Pubmed: 19212411
|